Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine

Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine. Photo credit: Tech Parks Arizona


February 27, 2020 — Emagine Solutions Technology, an award-winning medical software device company located in Tucson, announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market its VistaScan mobile ultrasound platform. 

The VistaScan platform transforms a clinician's cell phone or tablet into a portable ultrasound solution. The system consists of compatible FDA cleared ultrasound probes that interface with the VistaScan software application. VistaScan's proprietary patent-pending Dynamic Precise Point Measuring System enables a healthcare provider to maximize the accuracy of a mobile device's touchscreen to make highly precise, to-the-pixel measurements on the ultrasound image, thereby increasing diagnostic performance and speed.  

"The velocity and complexity of modern medicine is becoming overwhelming, and putting the power of ultrasound into the pockets of clinicians so they can use it for real time diagnosis right at the bedside is liberating and transformative," commented Dr. Berndt Schmit, Section Chief of Emergency Radiology at Banner University Medical Center at the University of Arizona and President of Humanitarian Radiology Development Corps.

Emagine Solutions Technology has already won a number of accolades prior to its launch of VistaScan, including grant funding from National Science Foundation and Roddenberry Foundation, the Flinn Foundation Bioscience Entrepreneurship award, National AURP Award, and was a Governor's Celebration of Innovation Finalist this year. The company is also a Pipeline Angels investment portfolio company. 

"Receiving FDA clearance is excellent validation of our technology and demonstrates the role handheld ultrasound will play in enhancing patient care," commented Courtney Williams, co-founder and CEO of Emagine Solutions Technology.

Emagine Solutions Technology is a certified Women's Business Enterprise by the Women's Business Enterprise Council and was founded to expand access to diagnostic ultrasound technology, particularly in the area of women's health. 

For more information: www.vistascan.co


Related Content

News | Computed Tomography (CT)

March 31, 2023 — Philips, a global leader in health technology, and Connally Memorial Medical Center (CMMC), today ...

Time March 31, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

March 30, 2023 — GenesisCare, one of the leading integrated cancer care providers in the United States, Australia, Spain ...

Time March 30, 2023
arrow
News | Radiology Business

March 27, 2023 — Swissray brand has a long history of pioneering digital x-ray technology. One of the first markets that ...

Time March 27, 2023
arrow
News | Nuclear Imaging

March 22, 2023 — A novel imaging modality that can visualize the distribution of medical radiopharmaceuticals with very ...

Time March 22, 2023
arrow
News | Lung Imaging

March 22, 2023 — The Riverain Technologies ClearRead Bone Suppression solution is now available on the Siemens ...

Time March 22, 2023
arrow
News | Digital Pathology

March 21, 2023 — Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and PathPresenter ...

Time March 21, 2023
arrow
News | Radiology Business

March 21, 2023 — Boston Imaging, a subsidiary of Samsung Electronics, Co. Ltd, appoints Eric Sumner as the new Digital ...

Time March 21, 2023
arrow
News | Digital Radiography (DR)

March 20, 2023 — A study by Emory Healthcare reports that Konica Minolta Healthcare’s Dynamic Digital Radiography (DDR) ...

Time March 20, 2023
arrow
News | X-Ray

March 20, 2023 — Researchers from UNSW Sydney have developed an algorithm which produces high-resolution modeled images ...

Time March 20, 2023
arrow
News | Radiopharmaceuticals and Tracers

March 16, 2023 — A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to ...

Time March 16, 2023
arrow
Subscribe Now